Table 6 Incidence of Adverse Events by total dose administered (regardless of the interval of dosing).
AE N = 30 | <=100 mg dose | Event Rate % | <=200 | Event Rate % | <=300 | Event Rate % |
|---|---|---|---|---|---|---|
Nausea | Â | Â | 2 | 6.7 | 3 | 10 |
Vomiting | Â | Â | 2 | 6.7 | 3 | 10 |
HTN | Â | Â | 1 | 3 | 3 | 10 |
Infection | Â | Â | Â | Â | 1 | 3 |
Liver Dysfunction | 1 | 3 | 2 | 6.7 | 3 | 10 |
Gastritis | Â | Â | 1 | 3 | Â | Â |
Dehydration | Â | Â | 1 | 3 | Â | Â |
Cholecystitis | Â | Â | Â | Â | 1 | 3 |
Anemia | Â | Â | 1 | 3 | Â | Â |
Pneumonia | Â | Â | 1 | 3 | Â | Â |
Anorexia | 2 | 6 | 1 | 3 | 1 | 3 |